SCHEMBL5586396

SCHEMBL5586396

Cc1ccc(C2NCCNC2=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.47
TSHR P16473 1/20 0.47
PRCP P42785 1/20 0.45
GID4 Q8IVV7 1/20 0.44
MAPT P10636 2/20 0.42
KDM1A O60341 2/20 0.41
MAP4K1 Q92918 1/20 0.41
ATM Q13315 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
RAB9A P51151 2/20 0.38
LMNA P02545 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ALDH1A1 P00352 1/20 0.36
PARP10 Q53GL7 1/20 0.36
PARP11 Q9NR21 1/20 0.36
TP53 P04637 2/20 0.36
NPC1 O15118 1/20 0.36
HTR2A P28223 2/20 0.35
HTR2C P28335 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31049590 0.81 MAP4K1 (0.41) SMN1; SMN2TSHRMAP4K1NPSR1LMNA
SCHEMBL1673497 0.81 SLC6A3 (0.47) PRCPKDM1AMAP4K1LMNAALDH1A1
SCHEMBL380027 0.81 TDP1 (0.50) SMN1; SMN2PRCPMAPTKDM1AMAP4K1
SCHEMBL9786155 0.81 TDP1 (0.50) SMN1; SMN2PRCPMAPTKDM1AMAP4K1
SCHEMBL17055320 0.81 SMN1; SMN2 (0.42) SMN1; SMN2MAPTKDM1AMAP4K1RAB9A
SCHEMBL10373386 0.80 GID4 (0.49) SMN1; SMN2GID4MAPTKDM1ARAB9A
SCHEMBL26986647 0.80 PRCP (0.44) PRCPGID4MAPTKDM1AMAP4K1
SCHEMBL596560 0.80 PRCP (0.44) PRCPGID4MAPTKDM1AMAP4K1
SCHEMBL6996372 0.77 L3MBTL1 (0.48) MAPTKDM1AMAP4K1MEN1KMT2A
SCHEMBL5543742 0.77 TSHR (0.41) SMN1; SMN2TSHRMAPTMAP4K1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8168658-B2 Inhibitors of histone deacetylase MERCK SHARP & DOHME CORP. (US) 2012-05-01 US disclosed
WO-2010107605-A1 CGRP RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2010-09-23 WO disclosed
US-20090069250-A1 Inhibitors of Histone Deacetylase MERCK SHARP & DOHME LLC 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069250-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC5, HDAC6 SMN1; SMN2 406/4885TSHR 1166/4885PRCP 1234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.